New NI Medical
NI Medical is dedicated to providing innovative non-invasive solutions for cardiovascular, hemodynamic, and fluid management challenges. Their flagship product, NICaS, is a non-invasive, easy-to-use, and cost-effective system designed to address clinical and financial challenges in managing various medical conditions including heart failure, hypertension, preeclampsia, dialysis, infectious diseases, and more. The company aims to establish NICaS and its ecosystem as the preferred solution for cardiovascular and hemodynamic management, offering accurate, reproducible, and clinically validated assessments that are mobile, patient-friendly, and capable of remote patient monitoring.
Industries
Nr. of Employees
small (1-50)
New NI Medical
Ha-Tidhar St. 5, Ra’anana, Israel, 4366507
Patents
Products
Non-invasive whole-body bioimpedance hemodynamic monitoring system
Compact patient-applied system that acquires whole‑body electrical bioimpedance signals and computes continuous or discrete hemodynamic parameters to support fluid and cardiovascular management in clinical and research settings.
Non-invasive whole-body bioimpedance hemodynamic monitoring system
Compact patient-applied system that acquires whole‑body electrical bioimpedance signals and computes continuous or discrete hemodynamic parameters to support fluid and cardiovascular management in clinical and research settings.
Services
Onboarding and training services enabling clinical staff to operate non-invasive hemodynamic monitoring systems and interpret hemodynamic profiles.
Centralized cloud platform for remote review and management of multiple patients, with secure transmission to core labs, remote specialist analysis and EMR connectivity.
Provision of hemodynamic measurement, standardized data collection and analysis support for academic studies and pharmaceutical clinical trials, including assistance with endpoints, inclusion criteria and dose-titration monitoring.
Onboarding and training services enabling clinical staff to operate non-invasive hemodynamic monitoring systems and interpret hemodynamic profiles.
Centralized cloud platform for remote review and management of multiple patients, with secure transmission to core labs, remote specialist analysis and EMR connectivity.
Provision of hemodynamic measurement, standardized data collection and analysis support for academic studies and pharmaceutical clinical trials, including assistance with endpoints, inclusion criteria and dose-titration monitoring.
Expertise Areas
- Non-invasive hemodynamic monitoring
- Clinical deployment across inpatient, ICU and outpatient settings
- Hemodynamic monitoring for dialysis and fluid management
- Perinatal, neonatal and pediatric hemodynamic assessment
Key Technologies
- Whole-body impedance cardiography
- Continuous hemodynamic parameter computation (CO, SV, CI, TPR, CPI, total body water)
- Wrist-to-ankle and two-sensor electrode configurations
- Cloud-based analytics and secure data transmission
News & Updates
NICaS Clinical Validation Studies
Multiple clinical studies validating NICaS technology in various conditions such as COVID-19, Heart Failure, and Hypertension.
NICaS Membership in American Heart Association
NI Medical is a member of the American Heart Association’s Innovators’ Network.
New Clinical Research Publications
Recent publications on NICaS applications in critical care, cardiology, obstetrics, and infectious diseases.
NICaS provides a simple and effective way to evaluate critically ill patients, including those with COVID-19.
NICaS helps reduce hospital readmissions and provides accurate hemodynamic data for personalized treatment.
Patent for NICaS Technology
NI Medical’s NICaS system received a patent for its innovative hemodynamic navigation technology.
NICaS Clinical Validation Studies
Multiple clinical studies validating NICaS technology in various conditions such as COVID-19, Heart Failure, and Hypertension.
NICaS Membership in American Heart Association
NI Medical is a member of the American Heart Association’s Innovators’ Network.
New Clinical Research Publications
Recent publications on NICaS applications in critical care, cardiology, obstetrics, and infectious diseases.
NICaS provides a simple and effective way to evaluate critically ill patients, including those with COVID-19.
NICaS helps reduce hospital readmissions and provides accurate hemodynamic data for personalized treatment.
Patent for NICaS Technology
NI Medical’s NICaS system received a patent for its innovative hemodynamic navigation technology.